A method of preparing an inorganic binder for medical use according to an embodiment of the present disclosure includes preparing a starting material using a-TCP powder and phosphate powder each of which has a predetermined particle size, producing a paste having a predetermined viscosity that is suitable for formation of a molded article having a predetermined shape by homogeneously mixing the starting material, adding water or saline to the homogeneously mixed starting material, and kneading the resulting mixture, subjecting the molded article to hydration reaction, and washing and drying the molded article having undergone the hydration reaction to obtain an inorganic binder containing OCP and HA crystal phases.

The invention relates to methods for manufacturing an inorganic polymer object from a precursor wherein the precursor consists of one or more or comprises one or more selected from the group consisting of gibbsite-containing bauxite, gibbsite containing residue of the Bayer process, thermally processed gibbsite-containing bauxite, and thermally processed gibbsite-containing residue of the Bayer process, the method comprising the steps of alkaline-activating said precursor, mixing the precursor, shaping the mixed precursor and hydrothermally curing the shaped precursor at a temperature between 70° C. and 350° C.

The invention relates to methods for manufacturing an inorganic polymer object from a precursor wherein the precursor consists of one or more or comprises one or more selected from the group consisting of gibbsite-containing bauxite, gibbsite containing residue of the Bayer process, thermally processed gibbsite-containing bauxite, and thermally processed gibbsite-containing residue of the Bayer process, the method comprising the steps of alkaline-activating said precursor, mixing the precursor, shaping the mixed precursor and hydrothermally curing the shaped precursor at a temperature between 70° C. and 350° C.

The invention relates to methods for manufacturing an inorganic polymer object from a precursor wherein the precursor consists of one or more or comprises one or more selected from the group consisting of gibbsite-containing bauxite, gibbsite containing residue of the Bayer process, thermally processed gibbsite-containing bauxite, and thermally processed gibbsite-containing residue of the Bayer process, the method comprising the steps of alkaline-activating said precursor, mixing the precursor, shaping the mixed precursor and hydrothermally curing the shaped precursor at a temperature between 70° C. and 350° C.

The invention relates to methods for manufacturing an inorganic polymer object from a precursor wherein the precursor consists of one or more or comprises one or more selected from the group consisting of gibbsite-containing bauxite, gibbsite containing residue of the Bayer process, thermally processed gibbsite-containing bauxite, and thermally processed gibbsite-containing residue of the Bayer process, the method comprising the steps of alkaline-activating said precursor, mixing the precursor, shaping the mixed precursor and hydrothermally curing the shaped precursor at a temperature between 70° C. and 350° C.

A process for the manufacturing of a slurry containing nucleating agents which comprises reacting at least one source of a Ca containing compound with at least one source of a Si containing compound, in an aqueous media and in the presence of a doping agent selected from the group consisting of P, B, S, and mixtures thereof; wherein: (i) the reaction is carried out at a temperature comprised from 100 to 350° C.; (ii) the total molar ratio Ca/Si is 1.5-2.5, and (iii) the total molar ratio doping agent/Si is 0.01-2; provided that: (a) when the sole doping agent is P, the total molar ratio P/Si is 0.1-2; (b) when the sole doping agent is B, the total molar ratio B/Si is 0.01-2, and (c) when the sole doping agent is S, the total molar ratio S/Si is 0.1-2.

A process for the manufacturing of a slurry containing nucleating agents which comprises reacting at least one source of a Ca containing compound with at least one source of a Si containing compound, in an aqueous media and in the presence of a doping agent selected from the group consisting of P, B, S, and mixtures thereof; wherein: (i) the reaction is carried out at a temperature comprised from 100 to 350° C.; (ii) the total molar ratio Ca/Si is 1.5-2.5, and (iii) the total molar ratio doping agent/Si is 0.01-2; provided that: (a) when the sole doping agent is P, the total molar ratio P/Si is 0.1-2; (b) when the sole doping agent is B, the total molar ratio B/Si is 0.01-2, and (c) when the sole doping agent is S, the total molar ratio S/Si is 0.1-2.

Systems and method for curing cementitious products are provided herein. In an example, a pressurized water saturator is used to create a CO.sub.2/H.sub.2O stream. The pressurized water saturator includes a carbon dioxide injection line disposed below a water level in the pressurized water saturator, an exit line disposed above the water level in the pressurized water saturator, and a pressure controller configured to hold a positive pressure of carbon dioxide in the pressurized water saturator.

A fiber cement material formulation comprising a cementitious binder, a siliceous material, fiber, alumina trihydrate and a bifunctional low density additive wherein the bifunctional low density additive comprises any one or more of diatomaceous earth, recycled autoclave fiber cement dust or cellulose dust. The fiber cement material formulation optionally further comprises a secondary low density additive which may be perlite. In some embodiments, a fiber cement article manufactured from the fiber cement material formulation comprises a density of approximately 1.1 g/cm.sup.3 or below.

A fiber cement material formulation comprising a cementitious binder, a siliceous material, fiber, alumina trihydrate and a bifunctional low density additive wherein the bifunctional low density additive comprises any one or more of diatomaceous earth, recycled autoclave fiber cement dust or cellulose dust. The fiber cement material formulation optionally further comprises a secondary low density additive which may be perlite. In some embodiments, a fiber cement article manufactured from the fiber cement material formulation comprises a density of approximately 1.1 g/cm.sup.3 or below.